CWG
LXRX icon

C WorldWide Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

C WorldWide Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,037
Closed -$171K – 129
2018
Q3 		$171K Buy
16,037
+2,224
+16% +$25.5K ﹤0.01% 128
2018
Q2 		$166K Hold
13,813
– – ﹤0.01% 127
2018
Q1 		$118K Sell
13,813
-388
-3% -$3.59K ﹤0.01% 124
2017
Q4 		$140K Sell
14,201
-1,945
-12% -$20.2K ﹤0.01% 121
2017
Q3 		$198K Buy
16,146
+5,353
+50% +$79.1K ﹤0.01% 124
2017
Q2 		$178K Sell
10,793
-884
-8% -$13.7K ﹤0.01% 123
2017
Q1 		$167K Buy
11,677
+280
+2% +$4.15K ﹤0.01% 122
2016
Q4 		$158K Sell
11,397
-11,203
-50% -$180K ﹤0.01% 118
2016
Q3 		$408K Buy
+22,600
New +$364K 0.01% 122

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
SGA
Sector Gamma AS Oslo, Norway $461M AUM 33.26% 1-Year Est. Return

C WorldWide Group's LXRX Position: Q4 2018 in Review

C WorldWide Group sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2018, closing a stake of 16,037 shares — an estimated $171K sold.

C WorldWide Group first reported a position in LXRX in Q3 2016 and held it in 9 quarters. The position peaked at $408K in Q3 2016. 122 funds tracked by Wall St. Rank hold LXRX as of Q4 2018.

  • C WorldWide Group reported no remaining Lexicon Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • C WorldWide Group sold 16,037 Lexicon Pharmaceuticals shares in Q4 2018, an estimated $171K.
  • C WorldWide Group first reported a position in Lexicon Pharmaceuticals in Q3 2016 and held it in 9 quarters.
  • C WorldWide Group's Lexicon Pharmaceuticals position peaked at $408K in Q3 2016.
  • 122 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2018.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.